EBM Technologies Incorporated (TPEX:8409)
Taiwan · Delayed Price · Currency is TWD 17.75
-0.35 (-1.93%)
Nov 12, 2026, 1:30 PM CST
EBM Technologies Market Cap
EBM Technologies has a market cap or net worth of 568 million as of November 11, 2026. It is the 37,619th most valuable company in the world and the 2,230th biggest in Taiwan. Its market cap has decreased by 17.63% in one year.
Market Cap
568.00M
Enterprise Value
508.07M
Revenue
237.52M
Global Rank
Country Rank
#2,230 Taiwan
PE Ratio
46.89
ChartMarket Cap Chart
Since April 13, 2010, EBM Technologies's market cap has decreased from 882.35M to 568.00M, a decrease of -35.63%. That is a compound annual growth rate of -2.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 568.00M | -18.39% |
| Dec 31, 2025 | 696.00M | -7.45% |
| Dec 31, 2024 | 752.00M | -6.00% |
| Dec 29, 2023 | 800.00M | 31.93% |
| Dec 30, 2022 | 606.40M | 6.16% |
| Dec 30, 2021 | 571.20M | 11.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 567.77B |
| Lin BioScience | 131.01B |
| Caliway Biopharmaceuticals | 109.50B |
| Heron Neutron Medical | 64.15B |
| TFBS Bioscience | 635.89M |
| Taiwan Advance Bio-Pharmaceutical | 621.00M |
| Perfect Medical Industry | 612.59M |
| SynCore Biotechnology Co.,Ltd | 581.98M |